Multiple sclerosis
Alerts and Notices
Synopsis

Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system. It is a demyelinating disease that damages myelin covering nerves in the brain and spinal cord. In general, the age of onset is between 20 and 50 years, although onset can occur in childhood; women are more likely to be affected than men.
Patients may initially present with optic neuritis or transverse myelitis, although there is a wide range of symptoms depending on where lesions occur. Attacks can include motor, sensory, visual, or autonomic symptoms. There may be relapses and remissions (relapsing-remitting multiple sclerosis [RRMS]) or steady accumulation of disease and disability (progressive MS). Over 80% of patients initially follow a relapsing-remitting course, characterized by recurrent neurologic deficits, followed by partial or complete recovery. Some of these patients may later develop a steady accumulation of deficits (secondary progressive MS). About 10%-15% of patients have a progressive course from the onset characterized by gradual onset of neurologic symptoms and continued clinical deterioration. There is no cure, and permanent neurologic deficits and cognitive decline usually occur as the disease progresses.
Patients may initially present with optic neuritis or transverse myelitis, although there is a wide range of symptoms depending on where lesions occur. Attacks can include motor, sensory, visual, or autonomic symptoms. There may be relapses and remissions (relapsing-remitting multiple sclerosis [RRMS]) or steady accumulation of disease and disability (progressive MS). Over 80% of patients initially follow a relapsing-remitting course, characterized by recurrent neurologic deficits, followed by partial or complete recovery. Some of these patients may later develop a steady accumulation of deficits (secondary progressive MS). About 10%-15% of patients have a progressive course from the onset characterized by gradual onset of neurologic symptoms and continued clinical deterioration. There is no cure, and permanent neurologic deficits and cognitive decline usually occur as the disease progresses.
Codes
ICD10CM:
G35 – Multiple sclerosis
SNOMEDCT:
24700007 – Multiple sclerosis
G35 – Multiple sclerosis
SNOMEDCT:
24700007 – Multiple sclerosis
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
- Neuromyelitis optica
- Acute disseminated encephalomyelitis
- Neurosarcoidosis
- Systemic lupus erythematosus
- Progressive multifocal leukoencephalitis
- Central nervous system (CNS) human immunodeficiency virus infection
- Lyme disease
- Balo concentric sclerosis
- Paraneoplastic encephalomyelitis
- Spinal cord tumor
- Spinal cord infarction
- Spinal arteriovenous malformation
- Vitamin B12 deficiency
- Copper deficiency
- Central pontine myelinolysis
- Brain tumor
- CNS lymphoma
- Gliomatosis cerebri
- Migraine headache
- Transient ischemic attack / stroke
- Small vessel ischemic disease
- Vasculitis
- Neuropathy
- Spinocerebellar degeneration
- Friedreich ataxia
- Leukodystrophy
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:01/22/2018
Last Updated:01/19/2022
Last Updated:01/19/2022